David P. Hochman files SEC Form 4 disclosures for Orchestra BioMed Holdings, Inc.. They have made 40 open-market trades across 5 companies since 2006, most recently 2026-09-10.
CIK 0001292834
40 open-market purchases totalling $1.6M since 2006, never a sale. Across 30 scored buys the stock is up 8.6% at ninety days, and 5.2 points ahead of the S&P over the same stretch.
31 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| OBIO | 1,067,463 | $5.8M |
| MOTS | 291,669 | $51K |
| CRBP | 7,000 | $32K |
| IMNR | 3,375,000 | — |
| NAKD | 70,721 | — |
| Total | $5.9M |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close. 2 holdings could not be priced and are excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 58% | 45% | 47% |
| Avg Move | +1.8% | +5.0% | +8.6% |
| Alpha | +2.2% | +4.0% | +5.2% |
| Scored | 31 | 31 | 30 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OBIO | BUY | 2026-09-03 | 2026-09-08 | $4.79 | $48K | +13.9% | +7.5% | — |
| OBIO | BUY | 2026-06-01 | 2026-06-02 | $3.83 | $19K | +5.5% | +8.0% | +30.2% |
| OBIO | BUY | 2026-05-15 | 2026-05-19 | $3.77 | $19K | -2.9% | +0.6% | +19.1% |
| OBIO | BUY | 2026-03-13 | 2026-03-16 | $4.29 | $43K | -3.2% | -1.5% | -14.0% |
| OBIO | BUY | 2025-11-14 | 2025-11-17 | $4.07 | $20K | +28.5% | +3.9% | -7.2% |
| OBIO | BUY | 2025-08-21 | 2025-08-25 | $2.49 | $15K | +3.4% | -9.0% | +82.0% |
| OBIO | BUY | 2025-08-04 | 2025-08-04 | $2.75 | $55K | -2.6% | -0.4% | +44.7% |
| OBIO | BUY | 2024-12-23 | 2024-12-26 | $4.66 | $19K | +14.3% | +18.9% | -6.8% |
| OBIO | BUY | 2024-12-18 | 2024-12-19 | $4.91 | $25K | +15.9% | +11.4% | -4.5% |
| OBIO | BUY | 2024-09-24 | 2024-09-26 | $4.79 | $48K | +1.6% | +19.8% | -2.7% |
| OBIO | BUY | 2024-08-14 | 2024-08-15 | $5.84 | $15K | +5.0% | -18.8% | +0.2% |
| OBIO | BUY | 2024-06-25 | 2024-06-26 | $6.95 | $7K | +15.9% | +8.8% | -33.3% |
| MOTS | BUY | 2020-12-04 | 2020-12-07 | $0.99 | $5K | -15.0% | -5.3% | +17.7% |
| MOTS | BUY | 2019-07-01 | 2019-07-01 | $3.00 | $30K | +1.3% | -12.6% | -35.9% |
| CRBP | BUY | 2019-03-15 | 2019-03-18 | $6.98 | $14K | -5.6% | -5.7% | -3.1% |
| MOTS | BUY | 2018-12-24 | 2018-12-26 | $2.70 | $54K | +42.5% | +53.6% | +47.9% |
| MOTS | BUY | 2018-11-16 | 2018-11-21 | $3.49 | $52K | +4.6% | -17.6% | +48.7% |
| MOTS | BUY | 2018-05-17 | 2018-05-21 | $5.49 | $27K | +17.8% | +23.2% | +9.0% |
| CRBP | BUY | 2018-05-14 | 2018-05-15 | $5.48 | $27K | -8.5% | -5.4% | -23.6% |
| CRBP | BUY | 2018-03-14 | 2018-03-15 | $6.67 | $33K | -14.2% | -3.6% | -10.2% |
| MOTS | BUY | 2018-02-16 | 2018-02-21 | $5.00 | $575K | +14.4% | +9.1% | +11.6% |
| CRBP | BUY | 2017-11-15 | 2017-11-16 | $6.55 | $33K | +9.9% | -3.5% | +3.5% |
| CRBP | BUY | 2017-11-10 | 2017-11-13 | $7.08 | $71K | +2.2% | +5.1% | +2.9% |
| CRBP | BUY | 2017-05-11 | 2017-05-12 | $6.18 | $21K | +4.7% | -7.8% | -9.3% |
| CRBP | BUY | 2016-11-18 | 2016-11-21 | $7.00 | $70K | -10.0% | +5.6% | +9.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.